Skip to main content

Urinary bladder bioprinting for fully autologous transplantation

Project description

Bioprinting bladder tissue

Certain conditions, including inflammation and cancer, require augmentation of the urinary bladder. However, the conventional approach of using bowel tissue suffers from risks and post-surgery complications. The EU-funded UroPrint project proposes to engineer bladder tissue for autologous transplantation using laser-induced forward transfer (LIFT) bioprinting technology. Using a prototype bioprinter, researchers will graft primary urothelial and smooth muscle cells onto a natural scaffold ensuring high cell viability and mimicking the function of the human bladder. UroPrint is expected to improve clinical outcomes and the quality of life of patients by reducing hospitalisation.

Call for proposal

H2020-FETOPEN-2018-2019-2020-01
See other projects for this call

Coordinator

IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON
Address
Soranou Efesiou 4
115 27 Athina
Greece
Activity type
Research Organisations
EU contribution
€ 769 875

Participants (5)

ASSOCIACAO DO INSTITUTO SUPERIOR TECNICO PARA A INVESTIGACAO E DESENVOLVIMENTO
Portugal
EU contribution
€ 400 935
Address
Avenida Rovisco Pais 1
1049 001 Lisboa
Activity type
Research Organisations
INSTITUTE OF COMMUNICATION AND COMPUTER SYSTEMS
Greece
EU contribution
€ 760 499,99
Address
Patission Str. 42
10682 Athina
Activity type
Research Organisations
OPTICS11 BV
Netherlands
EU contribution
€ 496 250
Address
De Boelelaan 1081
1081 HV Amsterdam
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
METATISSUE - BIOSOLUTIONS, LDA
Portugal
EU contribution
€ 555 875
Address
Pci Parque De Ciencia E Inovacao Edificio Central Via Do Conhecimento
3830-352 Ilhavo
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
ASPHALION SL
Spain
EU contribution
€ 75 000
Address
Calle Tarragona, Numeros 151-157, Planta 10, Bloqu
08014 Barcelona
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)